Inhaled antibiotic therapy in chronic respiratory diseases

Medicine and Dentistry

• Cystic Fibrosis 100%
• Chronic Respiratory Tract Disease 100%
• Inpatient 100%
• Antibiotics 75%
• Antibiotic Therapy 50%
• Infection 50%
• Bronchiectasis 50%
• Atypical Mycobacterium 50%
• Inhalation 25%
• Antiinfective Agent 25%
• Respiratory System 25%
• Methicillin Resistant Staphylococcus Aureus 25%
• Pseudomonas aeruginosa 25%
• Development 25%
• Host 25%
• Burkholderia 25%
• Species 25%
• Therapeutic Procedure 25%
• Pathogen 25%
• Tissues 25%
• Mechanism of Action 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Cystic Fibrosis 100%
• Chronic Respiratory Tract Disease 100%
• Antibiotic Agent 75%
• Infection 50%
• Bronchiectasis 50%
• Atypical Mycobacterium 50%
• Organisms 25%
• Antiinfective Agent 25%
• Pseudomonas aeruginosa 25%
• Methicillin-Resistant Staphylococcus Aureus 25%
• Burkholderia 25%
• Infectious Agent 25%
• Host 25%

Nursing and Health Professions

• Cystic Fibrosis 100%
• Antibiotic Agent 75%
• Infection 50%
• Antibiotic Therapy 50%
• Bronchiectasis 50%
• Patient 50%
• Antiinfective Agent 25%
• Clinical Practice 25%
• Methicillin-Resistant Staphylococcus Aureus 25%
• Bacterial Load 25%
• Electric Potential 25%
• Species 25%
• Aerosol 25%
• Nebulization 25%